Stock Scorer

CollPlant Biotechnologies Ltd (CLGN)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD. Every figure as a table ›

Revenue Quarterly

0 3.5M 7M 10.5M Q2 '18: 182K Q2 '19: 606K Q2 '20: 823K Q2 '21: 691K Q2 '22: 66K Q2 '23: 10.2M Q2 '24: 249K Q2 '25: 179K Q2 '18 Q2 '19 Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25

Gross Profit Quarterly

-3.5M 0 3.5M 7M 10.5M Q2 '18: 115K Q2 '19: 143K Q2 '20: 75K Q2 '21: 262K Q2 '22: 23K Q2 '23: 9.6M Q2 '24: -287K Q2 '25: -7K Q2 '18 Q2 '19 Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25

Operating Income Quarterly

-6M -4M -2M 0 2M 4M 6M Q2 '18: -1.4M Q2 '19: -1.8M Q2 '20: -1.9M Q2 '21: -3.1M Q2 '22: -4.2M Q2 '23: 5.7M Q2 '24: -4.4M Q2 '25: -3.2M Q2 '18 Q2 '19 Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25

Net Income Quarterly

-6M -4M -2M 0 2M 4M 6M Q2 '18: -1.5M Q2 '19: -1.2M Q2 '20: -2M Q2 '21: -3M Q2 '22: -4.3M Q2 '23: 5.8M Q2 '24: -4.2M Q2 '25: -3.3M Q2 '18 Q2 '19 Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25

Cost of Revenue Quarterly

0 300K 600K 900K Q2 '18: 67K Q2 '19: 463K Q2 '20: 748K Q2 '21: 429K Q2 '22: 43K Q2 '23: 615K Q2 '24: 536K Q2 '25: 186K Q2 '18 Q2 '19 Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25

Shares Outstanding Quarterly

0 50M 100M 150M Q2 '17: 130.6M Q2 '18: 4.3M Q2 '19: 4.7M Q2 '21: 10.2M Q2 '22: 11.1M Q2 '23: 11.8M Q2 '24: 11.5M Q2 '25: 11.8M Q2 '17 Q2 '18 Q2 '19 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS Annual

-1.80 -1.20 -0.60 0.00 0.60 1.20 1.80 FY21: 0.02 FY22: -1.53 FY23: -0.62 FY24: -1.45 FY25: -0.94 FY21 FY22 FY23 FY24 FY25

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.

Not drawn for CLGN: Operating Cash Flow, Free Cash Flow. Nothing in this filer's XBRL supports them for the periods asked for. That is a gap in the filing, not a zero, and drawing a flat line would be an invention.